Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Purpura

• Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia Management in Adults
• An Open-label Study of ALPN-303 in Subjects With Autoimmune Cytopenias
• Aspirin for Prophylaxis of TTP
• Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
• The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9
• Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP
• ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
• Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults
• Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
• Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules
• Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
• A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP
• The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura
• Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
• A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
• A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
• A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
• Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
• Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
• Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura
• Atorvastatin in Management of Newly Diagnosed ITP
• to Evaluate the Efficacy and Safety of Eltrombopag for Thrombocytopenia With Chronic HBV Infection
• Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura
• Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment
• A Study to Assess the Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP
• Rituximab Combining Bortezomib Versus Rituximab in Management of ITP
• The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.
• A Study of PRN1008 in Adult Patients With Immune Thrombocytopenia (ITP)
• A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)
• The Study of Different Dose Rituximab in the Treatment of ITP
• Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP
• Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care
• Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient
• Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis
• H. Pylori Eradication for Moderate ITP
• Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura
• The PROLONG Trial - Rituximab Maintenance Therapy in ITP
• A Randomized Multicenter Study for Isolated Skin Vasculitis
• Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
• Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis
• Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
• Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
• The Research of Standard Diagnosis and Treatment for Severe HSP in Children
• The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
• The Research of Standard Diagnosis and Treatment for HSPN in Children
• A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
• Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia
• Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects
• Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
• Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
• A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
• Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
• A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
• A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
• Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
• Octaplas Adult TTP Trial
• Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and Hands
• All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
• A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
• Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP
• Eltrombopag Phase III Study In Chinese Chronic ITP Patients
• Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
• rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP
• Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
• Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia
• Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
• Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
• Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT
• A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients
• Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
• A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501
• rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP
• Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
• Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
• A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
• Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
• A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
• Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.
• A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic
• Drug Use Investigation for REVOLADE (ITP)
• High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
• Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
• A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects
• Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP
• Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura
• A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
• Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect
• Promacta Pregnancy Registry
• Initial Treatment of Patients With Immune Thrombocytopenic Purpura
• The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
• Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
• The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
• The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
• Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
• Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
• Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
• Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
• Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
• Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
• A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
• Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
• Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
• Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)
• Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
• Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
• Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag
• Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
• LENS - Long-term Eltrombopag Observational Study
• ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders
• Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003
• Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
• P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura
• Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP
• Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Rituximab in Patients With Relapsed or Refractory TTP-HUS
• Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
• Eltrombopag Taste Testing in Healthy Adult Volunteers
• Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
• A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
• Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
• HSP-glomerulonephritis Trial: MP vs CyA
• Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
• Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
• Sirolimus for Autoimmune Disease of Blood Cells
• A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
• Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
• RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
• Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
• Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment
• EXTEND (Eltrombopag Extended Dosing Study)
• Safety Study of AMG 531 in Japanese Subjects With ITP
• Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN
• Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin
• Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
• Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy
• Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
• Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
• A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone
• Efficacy and Safety of IVIG-L in ITP Patients
• Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
• Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
• Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
• Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
• AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
• AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
• Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
• A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura